Targeted News Service

Experimental Drug Offers Hope for Patients with Advanced Pancreatic Cancer
April 14, 2026

NORMAN, Oklahoma, April 14 -- The University of Oklahoma issued the following news:

* * *

Experimental Drug Offers Hope for Patients with Advanced Pancreatic Cancer

*

OKLAHOMA CITY - Results from a Phase 3 clinical trial offer new hope for patients with advanced pancreatic cancer, showing the experimental drug daraxonrasib significantly extended survival compared with chemotherapy alone. Researchers at the University of Oklahoma Health Stephens . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form